Structural Intervention

About

Valve replacement surgery can be an effective, lifesaving treatment option for people with aortic or mitral valve diseases.

Aortic valve replacement is often required in older patients but the surgical risk is often extremely high. Transcatheter aortic valve implantation (TAVI) is an established therapy for intermediate and high surgical risk patients with symptomatic severe aortic valve stenosis.

Approximately 1.8% of the US population has mitral valve disease, and an estimated 106,000 surgeries per year are for the treatment of valvular heart disease. The durability of surgical mitral valve repairs and replacement are limited. There is a 25% rate of significant mitral regurgitation recurrence in surgical repairs at 2 years and a 44% rate of primary valvular failure at 15 years, leaving the patient with either symptomatic mitral regurgitation, stenosis or both.

Articles

The Expanding Role of Echocardiography in Interventional Cardiology

Citation:

European Cardiology 2010;6(2):71–6

The Future of Abdominal Aortic Aneurysm Treatment and the Role of Totally Percutaneous Endografting

Citation:

Interventional Cardiology 2010;5:86–9

Endovascular Aortic Aneurysm Repair in ‘Non-ideal’ Patients – Techniques and Outcomes

Citation:

Interventional Cardiology 2010;5:90–2

Management and Prevention of Vascular Complications Related to Transcatheter Aortic Valve Implantation and Aortic Aneurysm Repair Procedures - A Technical Note

Citation:

Interventional Cardiology 2010;5:81–5